Italy, June 17 -- Following its December 18, 2024 press release, MAIRE S.p.A. announces that its subsidiary NEXTCHEM and newcleo SA ("newcleo") have signed binding agreements to establish Nextcleo S.p.A. (Nextcleo), a newly incorporated joint venture company between NEXTCHEM and newcleo, in order to develop the conventional island and balance of plant of new generation commercial-scale nuclear plants based on newcleo's 200 MWe Advanced Modular Reactor (AMR).NEXTCHEM will own 60% of Nextcleo's share capital and newcleo the remaining 40%. Nextcleo will be fully consolidated by NEXTCHEM, which will retain operational control. The binding agreements also provide that NEXTCHEM will simultaneously be granted an initial stake of approximately 1.25...